C4 Therapeutics, Inc. engages in the development of targeted protein degradation science to develop a new generation of small molecule medicines used for treating diseases. It develops the Degronimid platform that incorporates small molecule binders to target disease-causing proteins and facilitate their destruction and clearance from the cell through the na...
NEXT Oncology Barcelona, Barcelona, Spain
University of Wisconsin, Madison, Wisconsin, United States
Institut Bergonie, Bordeaux Cedex, France
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
City of Hope, Duarte, California, United States
University of Iowa Hospital and Clinics, Iowa City, Iowa, United States
Massachusetts General Hospital, Boston, Massachusetts, United States
Emory University Hospital, Atlanta, Georgia, United States
Washington University School of St. Louis, Saint Louis, Missouri, United States